Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 268 | $18.92 | $5,071 | 166,243 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 2,527 | $18.54 | $46,841 | 143,673 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:19 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 2,053 | $18.54 | $38,055 | 204,005 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 4:16 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 250 | $18.54 | $4,634 | 29,173 (Direct) | View |
| 2025-02-28 Sale(A) | 2025-03-03 9:27 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 4,637 | $18.75 | $86,949 | 166,511 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 13,494 | $19.72 | $266,126 | 206,058 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 15,036 | $19.7 | $296,257 | 146,200 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,387 | $20.02 | $27,773 | 108,706 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 991 | $20.02 | $19,844 | 50,133 (Direct) | View |
| 2025-02-27 Sale(A) | 2025-03-03 9:26 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,014 | $19.71 | $39,688 | 29,423 (Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:28 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Innovation Officer | 4,637 | $18.75 | $86,949 | 166,511 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:28 pm | NovoCure Ltd | NVCR | Leupin Nicolas Chief Medical Officer | 991 | $20.02 | $19,844 | 50,133 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:27 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,387 | $20.02 | $27,773 | 108,706 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:27 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 15,036 | $19.7 | $296,257 | 146,200 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:26 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 13,494 | $19.72 | $266,126 | 206,058 (Direct) | View |
| 2025-02-27 Sale | 2025-03-03 4:26 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,014 | $19.71 | $39,688 | 29,423 (Direct) | View |
| 2025-01-11 Sale | 2025-01-15 4:23 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 2,160 | $26.81 | $57,906 | 31,437 (Direct) | View |
| 2024-11-02 Sale | 2024-11-06 4:27 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 44 | $16.69 | $734 | 79,217 (Direct) | View |
| 2024-10-31 Sale | 2024-11-04 4:34 pm | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 810 | $15.79 | $12,792 | 110,093 (Direct) | View |
| 2024-11-01 Sale | 2024-11-04 4:34 pm | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 598 | $15.94 | $9,531 | 161,236 (Direct) | View |
| 2024-11-01 Sale | 2024-11-04 4:32 pm | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 160 | $15.88 | $2,540 | 3,503 (Direct) | View |
| 2024-08-02 Sale | 2024-08-05 4:25 pm | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 688 | $20.14 | $13,857 | 219,179 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:43 pm | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 964 | $23.89 | $23,033 | 176,079 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:42 pm | NovoCure Ltd | NVCR | Scannell Timothy J Director | 964 | $23.89 | $23,027 | 14,210 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-01-06 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Brackmann Christoph CFO | 0 | $0 | 162,717 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 669 | $14.75 | 118,721 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Executive Officer | 373 | $14.75 | 219,552 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 412 | $14.75 | 415,640 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 400,000 | $0 | 415,640 (Direct) | View |
| 2024-11-04 Option Award | 2024-11-06 4:27 pm | N/A 2034-11-03 | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 45,620 | $16.59 | 79,217 (Direct) | View |
| 2024-11-04 Option Award | 2024-11-06 4:27 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 30,138 | $0 | 79,217 (Direct) | View |
Ownership | 2024-10-09 6:21 pm | N/A N/A | NovoCure Ltd | NVCR | Paravasthu Mukund Chief Operating Officer | 0 | $0 | 134,850 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:22 pm | N/A N/A | NovoCure Ltd | NVCR | Ben Arye Barak General Counsel | 930 | $12.24 | 118,052 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 1,055 | $12.24 | 252,290 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 1,239 | $12.24 | 15,228 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer | 1,286 | $12.24 | 220,465 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X EVP, Pres., Novocure Oncology | 1,736 | $12.24 | 161,834 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:16 pm | N/A N/A | NovoCure Ltd | NVCR | Puri Michal Nath Chief Human Resources Officer | 1,736 | $12.24 | 110,903 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-07 4:06 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer | 124,373 | $22.82 | 470,608 (Indirect) | View |
| 2024-06-05 Option Award | 2024-06-06 6:37 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Ocean Allyson J Director | 10,282 | $0 | 10,282 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 6:13 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Madden Martin J. Director | 10,282 | $0 | 25,902 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:55 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Hung David Director | 10,282 | $0 | 19,423 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:43 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Stafford Kristin Director | 10,282 | $0 | 10,282 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:43 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 10,282 | $0 | 176,079 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 5:42 pm | N/A 2034-06-04 | NovoCure Ltd | NVCR | Scannell Timothy J Director | 10,282 | $0 | 14,210 (Direct) | View |